Clinical trial
Neurocognitive and Genomic Predictors of Persistent Pain and Opioid Misuse After Spine Surgery
NCT06288256 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neurocognitive and Genomic Predictors of Persistent Pain and Opioid Misuse After Spine Surgery
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Observational
- Overall status
- Terminated
- Start date
- March 27, 2023
- Completion date
- August 31, 2026
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
elective spine surgery, lumbar spine pathology